Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mycobacterium

ABSTRACT: Genome sequencing of nontuberculosis mycobacteria

PROVIDER: PRJDB7717 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	DRR161184_1.fastq.gz	Fastqsanger.gz
	DRR161184_2.fastq.gz	Fastqsanger.gz
	DRR161185_1.fastq.gz	Fastqsanger.gz
	DRR161185_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 190

Similar Datasets

Mycobacterium senriense

Project description:Genome sequencing of novel nontuberculous mycobacteria TY59

| PRJDB10621 | ENA

Mycobacterium

Project description:Whole genome sequencing of non-tuberculosis mycobacteria type-strains

| PRJNA747101 | ENA

Mycobacterium

Project description:Rapid differentiation of mycobacteria

| PRJNA282173 | ENA

Mycobacterium sp. strain:20KCMC460

Project description:Genome sequencing of novel nontuberculous mycobacteria 20KCMC460

| PRJDB12741 | ENA

ChIP-chip of HA-tagged Lsr2 in Mycobacterium tuberculosis and Mycobacterium smegmatis

Project description:Bacterial nucleoid-associated proteins play important roles in chromosome organization and global gene regulation. We find that Lsr2 of Mycobacterium tuberculosis is a novel nucleoid-associated protein that specifically binds AT-rich regions of the genome, including regions encoding major virulence factors, such as the ESX secretion systems, the lipid virulence factors PDIM/PGL, and the PE/PPE families of antigenic proteins. Comparison of genome-wide binding data with expression data indicates that Lsr2 binding results in transcriptional repression. Domain swamping experiments demonstrate that Lsr2 has an N-terminal dimerization domain and a C-terminal DNA binding domain. NMR analysis of the DNA binding domain of Lsr2 and its interaction with DNA reveals a novel structure and a unique mechanism that enables Lsr2 to discriminately target AT-rich sequences through interactions with the minor groove of DNA. Taken together, we provide evidence that mycobacteria have employed a structurally distinct molecule with an apparently different DNA recognition mechanism to achieve an equivalent function as the Enterobacteriaceae H-NS, coordinating global gene regulation and virulence in this group of medically important bacteria.

2009-11-15 | GSE18652 | GEO

Mycobacterium tuberculosis microarray to screen anti-tuberculosis compounds

Project description:Feature reduction of microarray data from mycobacteria treated with a variety of various clinical and investigational drugs

2013-04-24 | GSE46212 | GEO

Mycobacterium spp.

Project description:Clinical isolates of Non-tuberculous Mycobacteria Genome sequencing and assembly

| PRJNA319839 | ENA

Mycobacterium tuberculosis microarray to screen anti-tuberculosis compounds

Project description:Feature reduction of microarray data from mycobacteria treated with a variety of various clinical and investigational drugs We are using feature reduction to demonstrate that subsets of biomarker genes representative of the whole genome are sufficient for MOA classification and deconvolution in a medium-throughput microfluidic format ultimately leading to a cost effective and rapid tool for routine antibacterial drug-discovery programs.

2013-04-24 | E-GEOD-46212 | biostudies-arrayexpress

Mycobacterium tuberculosis

Project description:Whole genome sequencing of drug-resistant Mycobacteria tuberculosis isolate from Myanmar

| PRJNA317032 | ENA

Mycobacterium bovis

Project description:Whole genome sequencing of Mycobacteria bovis directly from clinical tissue samples

| PRJNA752391 | ENA